ConductScience.org, home

Trial · NCT01557322

Results by group300

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Participants With American College of Rheumatology (ACR) CriteriaEtanerceptMorning Stiffness >1 Hour194participants
Number of Participants With American College of Rheumatology (ACR) CriterianbDMARDsMorning Stiffness >1 Hour1316participants
Number of Participants With American College of Rheumatology (ACR) CriteriaEtanerceptArthritis/Deformity of >=3 Joint Areas179participants
Number of Participants With American College of Rheumatology (ACR) CriterianbDMARDsArthritis/Deformity of >=3 Joint Areas1133participants
Number of Participants With American College of Rheumatology (ACR) CriteriaEtanerceptArthritis/Deformity of Hand/Joint160participants
Number of Participants With American College of Rheumatology (ACR) CriterianbDMARDsArthritis/Deformity of Hand/Joint1123participants
Number of Participants With American College of Rheumatology (ACR) CriteriaEtanerceptSymmetry175participants
Number of Participants With American College of Rheumatology (ACR) CriterianbDMARDsSymmetry978participants
Number of Participants With American College of Rheumatology (ACR) CriteriaEtanerceptNodules91participants
Number of Participants With American College of Rheumatology (ACR) CriterianbDMARDsNodules470participants
Number of Participants With American College of Rheumatology (ACR) CriteriaEtanerceptRheumatoid Factor Positive123participants
Number of Participants With American College of Rheumatology (ACR) CriterianbDMARDsRheumatoid Factor Positive927participants
Number of Participants With American College of Rheumatology (ACR) CriteriaEtanerceptErosions on Hand or Feet X-Ray116participants
Number of Participants With American College of Rheumatology (ACR) CriterianbDMARDsErosions on Hand or Feet X-Ray730participants
Number of Participants With Systemic FeaturesEtanerceptSicca Syndrome (n= 211, 1540)45participants
Number of Participants With Systemic FeaturesnbDMARDsSicca Syndrome (n= 211, 1540)166participants
Number of Participants With Systemic FeaturesEtanerceptSerosal Involvement (n= 211, 1540)7participants
Number of Participants With Systemic FeaturesnbDMARDsSerosal Involvement (n= 211, 1540)18participants
Number of Participants With Systemic FeaturesEtanerceptEye Involvement (n= 211, 1540)17participants
Number of Participants With Systemic FeaturesnbDMARDsEye Involvement (n= 211, 1540)93participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01557322/results